Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 11;58(5):652.
doi: 10.3390/medicina58050652.

Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes

Affiliations

Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes

Lavinia-Alexandra Moroianu et al. Medicina (Kaunas). .

Abstract

Over time, studies have shown the importance of determining serotonin levels to diagnose somatic and psychiatric disorders. There are theoretical premises and practical ways to achieve a subtle correlation between the existence of comorbid psychiatric disorders and somatic diseases caused by the changes observed in serotonin levels. The present study, classified as retrospective and quantitative, provides evidence for determining the serotonin levels in patients with diabetes and anxiety or depression. A total of 48 patients with diabetes type 2 were enrolled in the study. Blood glucose level, glycated haemoglobin, and serum serotonin were noted, and they completed Hamilton A and Beck Depression Inventory questionnaires. We found robust correlations between serum serotonin and blood glucose (Sig. = 0.008), serum serotonin and HbA1c (Sig. = 0.007), serum serotonin and anxiety (Sig. = 0.000), and serum serotonin and depression (Sig. = 0.000). It is also noteworthy that women recorded extreme values higher than men for glycated haemoglobin (95% confidence interval: 6.92-7.79 in women and 6.30-7.23 in men). In conclusion, using serotonin as a marker of the mentioned diseases in clinical practice is of significant utility, considering the benefits in terms of the evolution and prognosis of comorbidities in patients with type 2 diabetes and anxiety and depressive symptoms.

Keywords: anxiety; comorbidities; depression; prognosis; serotonin; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 2
Figure 2
Values obtained when testing serotonin.
Figure 3
Figure 3
Blood glucose test results.
Figure 4
Figure 4
Results of HbA1c values.
Figure 1
Figure 1
The frequency of patients’ declared ages at the time of testing.

References

    1. Beattir D.T., Smith J.A.M. Serotonin pharmacology in the gastrointestinal tract: A review. Naunyn Schmiedeberg’s Arch. Pharmacol. 2008;377:181–203. doi: 10.1007/s00210-008-0276-9. - DOI - PubMed
    1. Ghidul Serviciilor de Laborator Referinţele Specifice Tehnologiei de Lucru Utilizate. 2010. [(accessed on 31 March 2022)]. Available online: https://www.synevo.ro/hemograma/
    1. Saldanha D., Kumar N., Ryali V.S.S.R., Srivastava K., Pawar A.A. Serum Serotonin Abnormality in Depression. Med. J. Armed Forces India. 2009;65:108–112. doi: 10.1016/S0377-1237(09)80120-2. - DOI - PMC - PubMed
    1. Conversano C., Di Giuseppe M. Psychological factors as determinants of chronic conditions: Clinical and psychodynamic advance. Front. Psychol. 2021;12:86. doi: 10.3389/fpsyg.2021.635708. - DOI - PMC - PubMed
    1. Merlo E.M. Opinion Article: The role of psychological features in chronic diseases, advancements and perspectives. Mediterr. J. Clin. Psychol. 2019;7 doi: 10.6092/2282-1619/2019.7.2341. - DOI